T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
E.W. Scripps
SSP
$310M
| $547K | ﹤0.01% |
34,979
-7,736
| -18% | -$125K |
|
2052
TTM Technologies
TTMI
$14.6B
| $546K | ﹤0.01% |
34,869
-4,640
| -12% | -$74.6K |
|
2053
Genworth Financial
GNW
$3.77B
| $544K | ﹤0.01% |
174,978
-26,775
| -13% | -$92.6K |
|
|
NXGN
2054
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $542K | ﹤0.01% |
39,943
+9,300
| +30% | +$134K |
|
2055
Toyota
TM
$223B
| $539K | ﹤0.01% |
4,237
+237
| +6% | +$29.5K |
|
|
RDC
2056
DELISTED
Rowan Companies Plc
RDC
| $539K | ﹤0.01% |
34,406
-36,821
| -52% | -$517K |
|
2057
Group 1 Automotive
GPI
$3.14B
| $536K | ﹤0.01% |
7,548
-1,010
| -12% | -$76.9K |
|
2058
iShares MSCI South Korea ETF
EWY
$27.6B
| $532K | ﹤0.01% |
7,100
+3,100
| +78% | +$229K |
|
|
SHYF
2059
DELISTED
The Shyft Group
SHYF
| $532K | ﹤0.01% |
33,792
-25,200
| -43% | -$383K |
|
2060
Pembina Pipeline
PBA
$28.4B
| $531K | ﹤0.01% |
14,607
+3,407
| +30% | +$118K |
|
2061
Community Trust Bancorp
CTBI
$1.44B
| $530K | ﹤0.01% |
11,244
| – | – |
|
|
TRST
2062
Trustco Bank Corp NY
TRST
$971M
| $530K | ﹤0.01% |
11,520
-1,200
| -9% | -$54.8K |
|
2063
Federal Signal
FSS
$7.51B
| $529K | ﹤0.01% |
26,355
-15
| -0.1% | -$315 |
|
|
MDC
2064
DELISTED
M.D.C. Holdings, Inc.
MDC
| $529K | ﹤0.01% |
19,365
-14
| -0.1% | -$386 |
|
|
TTPH
2065
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $529K | ﹤0.01% |
4,195
+2,755
| +191% | +$353K |
|
2066
Provident Financial Services
PFS
$3.26B
| $528K | ﹤0.01% |
19,580
-10
| -0.1% | -$272 |
|
2067
First Busey Corp
BUSE
$2.58B
| $524K | ﹤0.01% |
17,515
-10
| -0.1% | -$311 |
|
|
ONIT
2068
Onity Group
ONIT
$330M
| $523K | ﹤0.01% |
11,130
+3,160
| +40% | +$159K |
|
|
NAVG
2069
DELISTED
Navigators Group Inc
NAVG
| $523K | ﹤0.01% |
10,748
-10
| -0.1% | -$534 |
|
2070
TIM SA
TIMB
$8.27B
| $522K | ﹤0.01% |
27,030
-887,973
| -97% | -$16.5M |
|
2071
Arrow Financial
AROW
$723M
| $521K | ﹤0.01% |
18,328
| – | – |
|
|
ZYNE
2072
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $521K | ﹤0.01% |
+41,632
| New | +$477K |
|
|
IPHS
2073
DELISTED
Innophos Holdings, Inc.
IPHS
| $520K | ﹤0.01% |
11,134
| – | – |
|
2074
iShares MSCI Australia ETF
EWA
$1.45B
| $517K | ﹤0.01% |
22,300
+10,100
| +83% | +$231K |
|
2075
Limoneira
LMNR
$250M
| $516K | ﹤0.01% |
23,028
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.